Grantham, Mayo, Van Otterloo & Co (GMO)
AGN

Grantham, Mayo, Van Otterloo & Co (GMO)’s Allergan Inc AGN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,464,872
Closed -$311M – 470
2014
Q4 		$311M Buy
1,464,872
+564,118
+63% +$112M 0.84% 29
2014
Q3 		$161M Sell
900,754
-72,297
-7% -$12M 0.43% 50
2014
Q2 		$165M Sell
973,051
-128,700
-12% -$20M 0.45% 46
2014
Q1 		$137M Buy
1,101,751
+373,757
+51% +$45.5M 0.36% 58
2013
Q4 		$80.9M Sell
727,994
-175,167
-19% -$16.7M 0.2% 74
2013
Q3 		$81.7M Buy
903,161
+42,430
+5% +$3.81M 0.22% 64
2013
Q2 		$72.5M Buy
+860,731
New +$89.3M 0.19% 63

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s AGN Position: Q1 2015 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,464,872 shares — an estimated $311M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $311M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,464,872 Allergan Inc shares in Q1 2015, an estimated $311M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Allergan Inc position peaked at $311M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2015, filed 14 May 2015.